Enhanced apoptosis of peripheral CD5-negative B lymphocytes from chronically hepatitis C virus-infected patients: reversal after antiviral treatment.
Toubi
Elias
E
Division of Clinical Immunology and Allergy, Bnai Zion Medical Center, Golomb St. 47, P.O.B. 4940, Haifa 31048, Israel. e.toubi@b-zion.org.il
Kessel
Aharon
A
Peri
Regina
R
Shmuel
Zehava
Z
Bamberger
Ellen
E
Sabo
Edmond
E
Zuckerman
Eli
E
D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D017209:Apoptosis; D015551:Autoimmunity; D001402:B-Lymphocytes / Q000276:immunology / Q000473:pathology* / Q000502:physiology; D018956:CD5 Antigens / Q000378:metabolism*; D002478:Cells, Cultured; D005260:Female; D005434:Flow Cytometry; D016174:Hepacivirus / Q000472:pathogenicity*; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology / Q000821:virology; D006801:Humans; D008297:Male; D008875:Middle Aged; D016328:NF-kappa B / Q000378:metabolism
D000998:Antiviral Agents; D018956:CD5 Antigens; D016328:NF-kappa B